BRIEF published on 03/25/2026 at 19:20, 3 months 1 day ago Gemina Laboratories Ltd. Announces Delisting from the CSE Shareholder Approval Delisting Leadership Change CSE Gemina Laboratories Ltd.
PRESS RELEASE published on 03/25/2026 at 19:15, 3 months 1 day ago Gemina Laboratories Ltd. Announces Delisting from the CSE Gemina Laboratories Ltd. (CSE:GLAB) to voluntarily delist its common shares from the Canadian Securities Exchange to cut costs while remaining a reporting issuer in key provinces. Dr. James Tansey becomes Chairman Canadian Securities Exchange Chairman Delist Gemina Laboratories Ltd. Dr. James Tansey
BRIEF published on 12/30/2025 at 15:50, 5 months 27 days ago Gemina Laboratories Announces Debenture Offering and Delisting Plans Delisting CSE Gemina Laboratories Board Composition Debenture Offering
PRESS RELEASE published on 12/30/2025 at 15:45, 5 months 27 days ago Debenture Offering and Delisting Gemina Laboratories Ltd. announces non-brokered private placement of secured debentures and intention to delist Common Shares from CSE for strategic reasons. Delisting subject to Shareholder approval Private Placement Delisting CSE Debentures Gemina Laboratories Ltd.
BRIEF published on 10/01/2025 at 20:15, 8 months 25 days ago Gemina Laboratories Ends Private Placement Transaction Private Placement Board Changes U.S. Securities Gemina Labs Financing Alternatives
PRESS RELEASE published on 10/01/2025 at 20:10, 8 months 25 days ago Gemina Laboratories Announces Termination of Transaction Gemina Laboratories Ltd. cancels $7M private placement, explores financing options. Board members Najib and Grace resign. Company focusing on biosensor and binding technologies for diagnostics Private Placement Diagnostics Industry Gemina Laboratories Ltd. Biosensor Technologies Board Members Resign
BRIEF published on 11/13/2024 at 17:05, 1 year 7 months ago Gemina Laboratories Announces Private Placement to Raise $7 Million Private Placement Capital Raising Gemina Laboratories Investment Risks Platform Development
PRESS RELEASE published on 11/13/2024 at 17:00, 1 year 7 months ago Gemina Laboratories Announces Private Placement Gemina Laboratories Ltd. announces a non-brokered private placement offering to raise up to $7,000,000. Proceeds will support platform development, production expansion, and business development Private Placement Offering Business Development Production Expansion Gemina Laboratories Ltd. Platform Development
BRIEF published on 07/10/2024 at 15:05, 1 year 11 months ago Gemina Laboratories Strategic Update Revenue Gemina Laboratories Diagnostics Licensing
PRESS RELEASE published on 07/10/2024 at 15:00, 1 year 11 months ago Gemina Laboratories Strategic Update Gemina Laboratories Ltd provides strategic update and progress summary in H1 2024, including new partnerships, maiden revenues, expanded solutions & protein production facility Partnerships Gemina Laboratories Ltd Strategic Update Protein Production Facility Commercial Revenues
Published on 06/26/2026 at 14:05, 6 hours 27 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 6 hours 32 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 7 hours 32 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 7 hours 47 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 19:50, 42 minutes ago Name Change Completed for C Capital's Swiss Listed Entity, Ticker Symbol CCAP Goes Live
Published on 06/26/2026 at 19:10, 1 hour 22 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/26/2026 at 18:04, 2 hours 28 minutes ago Turkiye Garanti Bankasi A.S.: Bond, subordinated debts, that can be included in the equity calculation debt instrument issuance CMB Application
Published on 06/26/2026 at 18:00, 2 hours 32 minutes ago PSP Swiss Property has sold the Richtipark in Wallisellen. The EBITDA guidance for the 2026 financial year has been increased.
Published on 06/26/2026 at 18:00, 2 hours 32 minutes ago VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M
Published on 06/26/2026 at 07:00, 13 hours 32 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 07:30, 1 day 13 hours ago Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
